ArticleAntimicrobial agents and chemotherapy2012

Characterization of resistance to the nonnucleoside NS5B inhibitor filibuvir in hepatitis C virus-infected patients.

Philip J F Troke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.